¼¼°èÀÇ º¥´õ ´ºÆ®·² ¾ÆÄ«À̺ê(VNA) ¹× PACS(ÀǷ῵»óÀúÀåÀü¼Û½Ã½ºÅÛ) ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : Á¦Ç° À¯Çüº°, º¥´õ À¯Çüº°, µµÀÔº°, ÃÖÁ¾»ç¿ëÀÚº°, ¿ëµµº°, ¸ð´Þ¸®Æ¼º°, Áö¿ªº°, Àü¸Á°ú ¿¹Ãø(2024-2031³â)
Global Vendor Neutral Archive (VNA) & PACS Market Size, Share & Trends Analysis Report By Product Type, By Vendor Type, By Deployment, By End User, By Application, By Modality, By Regional Outlook and Forecast, 2024 - 2031
»óǰÄÚµå : 1565188
¸®¼­Ä¡»ç : KBV Research
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 496 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,600 £Ü 5,208,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,320 £Ü 6,250,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,048 £Ü 8,750,000
PDF (Corporate User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

º¥´õ ´ºÆ®·² ¾ÆÄ«À̺ê(VNA) ¹× PACS(ÀǷ῵»óÀúÀåÀü¼Û½Ã½ºÅÛ) ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ Áß 9.3%ÀÇ CAGR·Î ½ÃÀå ¼ºÀåÇϸç, 2031³â±îÁö 83¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇ⠺м®

COVID-19 ÆÒµ¥¹Í ±â°£ Áß VNA ¹× PACS ½Ã½ºÅÛÀÇ ¼¼°è °ø±Þ¸ÁÀº Å« È¥¶õÀ» °Þ¾ú½À´Ï´Ù. ºÀ¼â, ¿©Çà Á¦ÇÑ ¹× ¹°·ù ¹®Á¦·Î ÀÎÇØ Áß¿äÇÑ Çϵå¿þ¾î ÄÄÆ÷³ÍÆ® ¹× ½Ã½ºÅÛ ºÎǰÀÇ ¹è¼ÛÀÌ Áö¿¬µÇ¾î ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ ¼³Ä¡ ¹× Á¤ºñ ´É·Â¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¸¹Àº VNA¿Í PACS, Çϵå¿þ¾î Á¦Á¶ ½Ã¼³µéÀÌ COVID-19·Î ÀÎÇØ ÀϽÃÀûÀÎ Æó¼â ¶Ç´Â ¿î¿µ Ãà¼Ò¿¡ Á÷¸éÇß½À´Ï´Ù. ÀÌ·Î ÀÎÇØ »ý»ê ÀÏÁ¤ÀÌ Áö¿¬µÇ°Å³ª °ø±Þ ºÎÁ·ÀÌ ¹ß»ýÇÏ¿© ½Ã½ºÅÛ ±¸Çö¿¡ ÇÊ¿äÇÑ ÄÄÆ÷³ÍÆ®ÀÇ °¡¿ë¼º¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÌó·³ COVID-19 ÆÒµ¥¹ÍÀº ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¿äÀÎ

ÀÇ·á ±â°üÀº ÀÇ·á µ¥ÀÌÅ͸¦ Áß¾Ó¿¡¼­ °ü¸®ÇÒ ¼ö ÀÖ´Â ÅëÇÕ Ç÷§ÆûÀ» ã´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, VNA ¼Ö·ç¼ÇÀº ´Ù¾çÇÑ Áø·á°ú¸ñ°ú ºÎ¼­ÀÇ ¿µ»ó µ¥ÀÌÅ͸¦ ÇϳªÀÇ Á¢±Ù °¡´ÉÇÑ ÀúÀå¼Ò¿¡ ÀúÀåÇÏ°í °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº ´Ù¾çÇÑ ÀÇ·á ȯ°æ °£ÀÇ ¿øÈ°ÇÑ µ¥ÀÌÅÍ ¾×¼¼½º ¹× °ü¸®¸¦ Áö¿øÇÏ¿© Á¾ÇÕÀûÀΠȯÀÚ °ü¸®¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÛ¿ëÇÕ´Ï´Ù. °á·ÐÀûÀ¸·Î, ÅëÇÕ ÇコÄÉ¾î ½Ã½ºÅÛ ¹× ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ´Ù¾çÇÑ ¿µ»ó Áø´Ü ¹æ¹ý(MRI, CT ½ºÄµ, ¿¢½º·¹ÀÌ µî)À» »ç¿ëÇϸç, °¢±â ´Ù¸¥ Çü½ÄÀ¸·Î µ¥ÀÌÅ͸¦ »ý¼ºÇϴµ¥, VNA´Â ÀÌ·¯ÇÑ ´Ù¾çÇÑ Áø´Ü ¹æ¹ýÀÇ µ¥ÀÌÅ͸¦ ÀúÀåÇÏ°í °ü¸®ÇÒ ¼ö Àִ ǥÁØÈ­µÈ Ç÷§ÆûÀ» Á¦°øÇÏ¿© ´Ù¾çÇÑ ½Ã½ºÅÛ °£ÀÇ ¿øÈ°ÇÑ ÅëÇÕ°ú ¾×¼¼½º¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ½Ã½ºÅÛ °£ÀÇ ¿øÈ°ÇÑ ÅëÇÕ°ú Á¢±ÙÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº ¼Ò½º¿¡ °ü°è¾øÀÌ À̹ÌÁö µ¥ÀÌÅÍ¿¡ ½±°Ô Á¢±ÙÇϰí ÇØ¼®ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. µû¶ó¼­ »óÈ£ ¿î¿ë¼º ¹× µ¥ÀÌÅÍ °øÀ¯¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

VNA ¹× PACS ½Ã½ºÅÛ ±¸Ãà¿¡´Â Çϵå¿þ¾î, ¼ÒÇÁÆ®¿þ¾î ¹× ÀÎÇÁ¶ó¿¡ ¸¹Àº ÀÚº» ÁöÃâÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ º¹ÀâÇÑ ¿ä±¸ »çÇ×À» Áö¿øÇÏ·Á¸é °í¼º´É ¼­¹ö, ½ºÅ丮Áö ½Ã½ºÅÛ ¹× ³×Æ®¿öÅ© ÀÎÇÁ¶ó°¡ ÇÊ¿äÇÕ´Ï´Ù. ƯÈ÷ ¼Ò±Ô¸ð ÀÇ·á ½Ã¼³ ¹× Á¶Á÷¿¡¼­´Â ÀÌ·¯ÇÑ ÀÎÇÁ¶ó¸¦ ȹµæÇϰí À¯ÁöÇÏ´Â µ¥ µå´Â ºñ¿ëÀÌ ¾öû³ª°Ô Ŭ ¼ö ÀÖ½À´Ï´Ù. °á·ÐÀûÀ¸·Î, VNA ¹× PACS ¼Ö·ç¼ÇÀÇ ³ôÀº Ãʱ⠺ñ¿ë°ú ±¸ÇöÀÇ ¾î·Á¿òÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.

Á¦Ç° À¯Çü Àü¸Á

Á¦Ç° À¯Çü¿¡ µû¶ó ½ÃÀåÀº VNA¿Í PACS·Î ³ª´µ¸ç, 2023³â PACS ºÎ¹®Àº ½ÃÀå¿¡¼­ 43%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. PACS(¿µ»ó º¸°ü ¹× Åë½Å ½Ã½ºÅÛ)´Â ÀÇ·á ¿µ»ó µ¥ÀÌÅÍÀÇ Áß¾Ó ÁýÁᫎ ÀúÀå¼Ò¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Áß¾Ó ÁýÁßÈ­¸¦ ÅëÇØ ´Ù¾çÇÑ ¾ç½Ä°ú ¼Ò½ºÀÇ À̹ÌÁö µ¥ÀÌÅ͸¦ ÇÑ °÷¿¡ ÀúÀåÇÏ¿© ÀÇ·á Àü¹®°¡°¡ ȯÀÚ À̹ÌÁö¿¡ ½±°Ô ¾×¼¼½ºÇÏ°í °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù.

º¥´õ À¯Çüº° Àü¸Á

º¥´õ À¯Çüº°·Î º¸¸é ½ÃÀåÀº µ¶¸³ º¥´õ¿Í Ÿ»ç º¥´õ·Î ³ª´¹´Ï´Ù. Ÿ»ç º¥´õ ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 40%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ÿ»ç °ø±Þ¾÷ü´Â ƯÁ¤ ¿µ»ó Àåºñ ¹× ¼ÒÇÁÆ®¿þ¾î °ø±Þ¾÷ü¿¡ ÀÇÁ¸ÇÏÁö ¾Ê´Â VNA ¹× PACS ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á߸³¼ºÀ» ÅëÇØ ´Ù¾çÇÑ Á¦Á¶¾÷üÀÇ ´Ù¾çÇÑ ±âÁ¸ ½Ã½ºÅÛ°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀÌ °¡´ÉÇÏ¿© ÀÇ·á ±â°üÀÌ ¿µ»ó µ¥ÀÌÅ͸¦º¸´Ù È¿°úÀûÀ¸·Î ÅëÇÕÇÏ°í °ü¸® ÇÒ ¼ö ÀÖ½À´Ï´Ù.

µµÀÔ Àü¸Á

¹èÄ¡¸¦ ±âÁØÀ¸·Î ½ÃÀåÀº ¿ÂÇÁ·¹¹Ì½º, Ŭ¶ó¿ìµå ±â¹Ý, ÇÏÀ̺긮µå ¸ðµ¨·Î ºÐ·ùµÇ¸ç, 2023³â¿¡´Â Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®ÀÌ ½ÃÀå¿¡¼­ 32%ÀÇ ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀº ¶Ù¾î³­ È®À强À» Á¦°øÇϸç, ÀÇ·á ±â°üÀº Áõ°¡ÇÏ´Â ¿µ»ó µ¥ÀÌÅÍÀÇ ¾ç¿¡ µû¶ó ½ºÅ丮Áö ¿ë·®À» È®ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È®À强À» ÅëÇØ Ŭ¶ó¿ìµå ±â¹Ý VNA ¹× PACS ½Ã½ºÅÛÀº ¹°¸®Àû ÀÎÇÁ¶ó¿¡ ´ëÇÑ ´ë±Ô¸ð ¼±Çà ÅõÀÚ ¾øÀ̵µ Áõ°¡ÇÏ´Â µ¥ÀÌÅÍ ¼ö¿ä¿¡ È¿À²ÀûÀ¸·Î ´ëÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚ Àü¸Á

ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó ½ÃÀåÀº º´¿ø ¹× Ŭ¸®´Ð, Áø´Ü¼¾ÅÍ, ±âŸ·Î ³ª´¹´Ï´Ù. Áø´Ü¼¾ÅÍ ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 21%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. Áø´Ü¼¾ÅÍ´Â ¼­ºñ½º¸¦ °­È­Çϰí ȯÀÚ Ä¡·á¸¦ °³¼±Çϱâ À§ÇØ °í±Þ À̹Ì¡ ±â¼ú°ú µ¥ÀÌÅÍ °ü¸® ½Ã½ºÅÛ¿¡ Á¡Á¡ ´õ ÀÇÁ¸Çϰí ÀÖÀ¸¸ç, VNA¿Í PACS ¼Ö·ç¼ÇÀÇ ÅëÇÕÀ» ÅëÇØ ÀÌ·¯ÇÑ ½Ã¼³Àº ¿î¿µÀ» °£¼ÒÈ­ÇÏ°í º´¿ø°úÀÇ Çù·ÂÀ» ÃËÁøÇϸç Àû½Ã¿¡ Áø´Ü Á¤º¸¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¦°øÇÕ´Ï´Ù.

¿ëµµ Àü¸Á

¿ëµµ¿¡ µû¶ó ½ÃÀåÀº ½ÉÀåÇÐ, Á¤Çü¿Ü°ú, Á¾¾çÇÐ, ½Å°æÇÐ, »êºÎÀΰú, ±âŸ·Î ³ª´¹´Ï´Ù. Á¾¾çÇÐ ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 22%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. Á¾¾çÇÐÀº PET, CT, MRI, ÃÊÀ½ÆÄ µî ´Ù¾çÇÑ ¿µ»ó Áø´Ü ¹æ¹ýÀ» »ç¿ëÇÏ¿© ¾ÏÀ» Áø´Ü, º´±â ¹× ¸ð´ÏÅ͸µÇϸç, VNA ¹× PACS ½Ã½ºÅÛÀº ÀÌ·¯ÇÑ ´Ù¾çÇÑ ¿µ»ó Æ÷¸ËÀ» ÅëÇÕµÈ ½Ã½ºÅÛÀ¸·Î ÅëÇÕÇÏ¿© ¿©·¯ ¾ç½Ä¿¡ °ÉÃÄ È¯ÀÚ µ¥ÀÌÅ͸¦ Á¾ÇÕÀûÀ¸·Î °ü¸®ÇÏ°í °ËÅäÇÒ ¼ö ÀÖµµ·Ï ÅëÇÕÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù.

¸ð´õ´ÏƼÀÇ Àü¸Á

¾ç½ÄÀ» ±âÁØÀ¸·Î ½ÃÀåÀº ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ, À¯¹æ Á¶¿µ¼ú, MRI, ÃÊÀ½ÆÄ, ¿¢½º·¹ÀÌ, PET·Î ºÐ·ùµÇ¸ç, 2023³â¿¡´Â ¿¢½º·¹ÀÌ ºÎ¹®ÀÌ ½ÃÀå¿¡¼­ 22%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ¿¢½º·¹ÀÌ À̹ÌÁö´Â °ñÀý¿¡¼­ °¨¿°¿¡ À̸£±â±îÁö ´Ù¾çÇÑ »óŸ¦ °¨ÁöÇÏ´Â µ¥ È¿°úÀûÀ̱⠶§¹®¿¡ ÀÇ·á ¼­ºñ½º¿¡¼­ °¡Àå ºó¹øÇÑ Áø´Ü Åø Áß ÇϳªÀÔ´Ï´Ù. ÀÇ·á ºÐ¾ß¿¡¼­ °¡Àå ¸¹ÀÌ »ç¿ëµÇ´Â Áø´Ü Åø Áß Çϳª·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ¸ÅÀÏ »ý¼ºµÇ´Â ¹æ´ëÇÑ ¾çÀÇ ¿¢½º·¹ÀÌ À̹ÌÁö·Î ÀÎÇØ VNA ¹× PACS¿Í °°Àº ½ºÅ丮Áö ¹× °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, ¿¢½º·¹ÀÌ´Â ÀÏ»ó ¹× ÀÀ±Þ »óȲ¿¡¼­ »ç¿ëµÇ¾î ÀÇ·á ¿µ»ó ó¸®ÀÇ Çʼö ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î º¸¸é ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«·Î ºÐ¼®µÇ¾ú½À´Ï´Ù. ºÏ¹Ì´Â 2023³â ½ÃÀå¿¡¼­ 39%ÀÇ ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. ºÏ¹Ì, ƯÈ÷ ¹Ì±¹°ú ij³ª´Ù´Â °íµµ·Î ¹ßÀüÇϰí Á¤±³ÇÑ ÀÇ·á ÀÎÇÁ¶ó¸¦ ÀÚ¶ûÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº Çö´ë ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ÇʼöÀûÀÎ VNA ¹× PACS¿Í °°Àº ÷´Ü ¿µ»ó ¼Ö·ç¼ÇÀ» äÅÃÇÒ ¼ö ÀÖ´Â °ß°íÇÑ È¯°æÀ» Á¶¼ºÇÕ´Ï´Ù. ºÏ¹ÌÀÇ ÇコÄÉ¾î ºÎ¹®Àº »õ·Î¿î ±â¼úÀ» ºü¸£°Ô äÅÃÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå °³°ü

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå °æÀï ºÐ¼® - ¼¼°è

Á¦5Àå ¼¼°è º¥´õ ´ºÆ®·² ¾ÆÄ«À̺ê(VNA) ¹× PACS(ÀǷ῵»óÀúÀåÀü¼Û½Ã½ºÅÛ) ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦6Àå ¼¼°è º¥´õ ´ºÆ®·² ¾ÆÄ«À̺ê(VNA) ¹× PACS(ÀǷ῵»óÀúÀåÀü¼Û½Ã½ºÅÛ) ½ÃÀå : º¥´õ À¯Çüº°

Á¦7Àå ¼¼°è º¥´õ ´ºÆ®·² ¾ÆÄ«À̺ê(VNA) ¹× PACS(ÀǷ῵»óÀúÀåÀü¼Û½Ã½ºÅÛ) ½ÃÀå : µµÀÔº°

Á¦8Àå ¼¼°è º¥´õ ´ºÆ®·² ¾ÆÄ«À̺ê(VNA) ¹× PACS(ÀǷ῵»óÀúÀåÀü¼Û½Ã½ºÅÛ) ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ¼¼°è º¥´õ ´ºÆ®·² ¾ÆÄ«À̺ê(VNA) ¹× PACS(ÀǷ῵»óÀúÀåÀü¼Û½Ã½ºÅÛ) ½ÃÀå : ¿ëµµº°

Á¦10Àå ¼¼°è º¥´õ ´ºÆ®·² ¾ÆÄ«À̺ê(VNA) ¹× PACS(ÀǷ῵»óÀúÀåÀü¼Û½Ã½ºÅÛ) ½ÃÀå : ¸ð´Þ¸®Æ¼º°

Á¦11Àå ¼¼°è º¥´õ ´ºÆ®·² ¾ÆÄ«À̺ê(VNA) ¹× PACS(ÀǷ῵»óÀúÀåÀü¼Û½Ã½ºÅÛ) ½ÃÀå : Áö¿ªº°

Á¦12Àå ±â¾÷ °³¿ä

Á¦13Àå º¥´õ ´ºÆ®·² ¾ÆÄ«À̺ê(VNA) ¹× PACS(ÀǷ῵»óÀúÀåÀü¼Û½Ã½ºÅÛ) ½ÃÀåÀÇ ¼º°ø Çʼö Á¶°Ç

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Vendor Neutral Archive (VNA) & PACS Market size is expected to reach $8.3 billion by 2031, rising at a market growth of 9.3% CAGR during the forecast period.

In 2023, the Europe region generated 29% revenue share in the market. The European Union is working towards creating the European Health Data Space to improve data sharing and interoperability across member states. VNA systems are crucial for achieving the interoperability required for such initiatives by providing a standardized platform for managing diverse imaging data. European healthcare systems are pushing for medical imaging and data management standardization. PACS and VNA systems support this goal by enabling the integration of imaging data from various sources into a single, standardized platform.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In February, 2024, Hyland Software, Inc. announced the partnership with iTernity, a software company that enhances healthcare data storage. Their partnership integrates eternity iCAS FS with Hyland Healthcare's Acuo VNA, an advanced platform consolidating imaging data from various sources into a unified repository, supporting DICOM and multimedia formats for seamless integration. Moreover, In October, 2022, GE HealthCare Technologies, Inc. teamed up with Tribune Health, a Software company to enhance digital pathology with integrated solutions. The collaboration aims to merge Tribun's Health Suite data with GE's VNA, Edison Catalog, for a comprehensive patient record. This integration will improve pathology report accuracy, speed up diagnoses, and foster collaboration in oncology.

COVID 19 Impact Analysis

During the COVID-19 pandemic, the global supply chains for VNA and PACS systems experienced significant disruptions. Lockdowns, travel restrictions, and logistical challenges led to delays in delivering critical hardware components and system parts, affecting the ability to deploy and maintain these systems. Many VNA and PACS, hardware manufacturing facilities, faced temporary closures or reduced operations due to COVID-19. This resulted in delays in production schedules and supply shortages, impacting the availability of necessary components for system implementation. Thus, the COVID-19 pandemic had a negative impact on the market.

Market Growth Factors

Healthcare organizations increasingly seek unified platforms that allow for centralized medical data management. VNA solutions can store and manage imaging data from various modalities and departments in a single, accessible repository. This integration supports seamless data access and management across different healthcare settings, critical for comprehensive patient care. In conclusion, the rising demand for integrated healthcare systems and solutions drives the market's growth.

Additionally, Healthcare providers are using a variety of imaging modalities (e.g., MRI, CT scans, X-rays), each producing data in different formats. VNAs offer a standardized platform for storing and managing data from these diverse modalities, enabling seamless integration and access across different systems. This integration is crucial for ensuring that imaging data can be easily accessed and interpreted regardless of the source. Therefore, the growing need for interoperability and data sharing propels the market's growth.

Market Restraining Factors

VNA and PACS systems deployment requires substantial capital expenditure for hardware, software, and infrastructure. High-performance servers, storage systems, and network infrastructure are needed to support the complex requirements of these systems. The costs associated with acquiring and maintaining this infrastructure can be prohibitive, especially for smaller healthcare facilities and organizations. In conclusion, VNA and PACS solutions' high initial costs and implementation challenges are hindering the market's growth.

Product Type Outlook

Based on product type, the market is divided into VNA and PACS. In 2023, the PACS segment attained 43% revenue share in the market. Picture Archiving and Communication Systems (PACS) provide a centralized repository for medical imaging data. This centralization ensures that imaging data from various modalities and sources are stored in one location, making it easier for healthcare professionals to access and manage patient images.

Vendor Type Outlook

By vendor type, the market is divided into independent vendors and third-party vendors. The third-party vendor segment procured 40% revenue share in the market in 2023. Third-party vendors provide VNA and PACS solutions agnostic to specific imaging equipment or software providers. This neutrality allows for seamless integration with various existing systems from different manufacturers, enabling healthcare organizations to consolidate and manage their imaging data more effectively.

Deployment Outlook

Based on deployment mode, the market is categorized into on-premise, cloud-based, and hybrid model. In 2023, the cloud-based segment registered 32% revenue share in the market. Cloud-based solutions offer exceptional scalability, allowing healthcare organizations to expand their storage capacities in response to the increasing volumes of imaging data. This scalability ensures that cloud-based VNA and PACS systems can efficiently accommodate growing data needs without requiring significant upfront investment in physical infrastructure.

End User Outlook

On the basis of end user, the market is divided into hospitals & clinics, diagnostic centers, and others. The diagnostic centers segment held 21% revenue share in the market in 2023. Diagnostic centers increasingly rely on advanced imaging technologies and data management systems to enhance their services and improve patient care. The integration of VNA and PACS solutions enables these facilities to streamline their operations, facilitate collaboration with hospitals, and provide timely diagnostic insights.

Application Outlook

Based on application, the market is divided into cardiology, orthopedic, oncology, neurology, obstetrics & gynecology, and others. The oncology segment attained 22% revenue share in the market in 2023. Oncology involves using various imaging modalities, such as PET, CT, MRI, and ultrasound, to diagnose, stage, and monitor cancer. VNA and PACS systems are crucial for integrating these diverse imaging formats into a unified system, enabling comprehensive management and review of patient data across multiple modalities.

Modality Outlook

On the basis of modality, the market is segmented into computed tomography, mammography, MRI, ultrasound, X-rays, and PET. In 2023, the X-rays segment attained 22% revenue share in the market. X-ray imaging remains one of healthcare's most frequently used diagnostic tools due to its effectiveness in detecting various conditions, from fractures to infections. Daily, the high volume of X-ray images generated drives significant demand for storage and management solutions, such as VNA and PACS. X-rays are utilized in routine and emergency settings, making them a staple in medical imaging.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 39% revenue share in the market in 2023. North America, particularly the United States and Canada, boasts a highly advanced and sophisticated healthcare infrastructure. This development creates a robust environment for adopting advanced imaging solutions like VNA and PACS, integral to modern healthcare delivery. The healthcare sector in North America is quick to adopt new technologies.

Recent Strategies Deployed in the Market

List of Key Companies Profiled

Global Vendor Neutral Archive (VNA) & PACS Market Report Segmentation

By Product Type

By Vendor Type

By Deployment

By End User

By Application

By Modality

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Competition Analysis - Global

Chapter 5. Global Vendor Neutral Archive (VNA) & PACS Market by Product Type

Chapter 6. Global Vendor Neutral Archive (VNA) & PACS Market by Vendor Type

Chapter 7. Global Vendor Neutral Archive (VNA) & PACS Market by Deployment

Chapter 8. Global Vendor Neutral Archive (VNA) & PACS Market by End User

Chapter 9. Global Vendor Neutral Archive (VNA) & PACS Market by Application

Chapter 10. Global Vendor Neutral Archive (VNA) & PACS Market by Modality

Chapter 11. Global Vendor Neutral Archive (VNA) & PACS Market by Region

Chapter 12. Company Profiles

Chapter 13. Winning Imperatives for Vendor Neutral Archive (VNA) & PACS Market

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â